Natasha Hernday
CIK 1780547 · last filed 2026-05-26
Natasha Hernday is a corporate insider who has filed 19 SEC Form 4 insider transactions across 5 companies since 2019. The most recent filing, for XOMAP, was dated May 26, 2026. Current disclosed insider exposure totals $220.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$220.3K
5
19
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XOMAP | Director | 4,000 | $25.46 | $101.9K | $0 | 7 | 2026-05-26 |
| JANX | Director | 8,731 | $13.56 | $118.4K | $0 | 3 | 2025-06-13 |
| ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Director | — | $64.97 | — | $0 | 6 | 2024-05-20 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | Director | 75,826 | — | — | $0 | 2 | 2020-08-24 |
| XOMA | Director | — | $41.79 | — | $0 | 1 | 2020-07-02 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | XOMAP | Grant (A) | +3,586 | $0 | EDGAR |
| 2025-06-13 | JANX | Grant (A) | +3,750 | $0 | EDGAR |
| 2025-05-23 | XOMAP | Grant (A) | +5,971 | $0 | EDGAR |
| 2024-07-24 | JANX | Grant (A) | +1,231 | $0 | EDGAR |
| 2024-07-22 | JANX | Grant (A) | +7,500 | $0 | EDGAR |
| 2024-05-20 | ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Disp (D) | — | $0 | EDGAR |
| 2024-05-17 | XOMAP | Grant (A) | +3,035 | $0 | EDGAR |
| 2024-01-04 | ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | XOMAP | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Grant (A) | — | $0 | EDGAR |